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Abstract
Background: The World Health Organization recommends that national malaria programmes universally distribute
long-lasting insecticide-treated bed nets (LLINs). LLINs provide effective insecticide protection for at least three
years while conventional nets must be retreated every 6-12 months. LLINs may also promise longer physical
durability (lifespan), but at a higher unit price. No prospective data currently available is sufficient to calculate the
comparative cost effectiveness of different net types. We thus constructed a model to explore the cost
effectiveness of LLINs, asking how a longer lifespan affects the relative cost effectiveness of nets, and if, when and
why LLINs might be preferred to conventional insecticide-treated nets. An innovation of our model is that we also
considered the replenishment need i.e. loss of nets over time.
Methods: We modelled the choice of net over a 10-year period to facilitate the comparison of nets with different
lifespan (and/or price) and replenishment need over time. Our base case represents a large-scale programme
which achieves high coverage and usage throughout the population by distributing either LLINs or conventional
nets through existing health services, and retreats a large proportion of conventional nets regularly at low cost. We
identified the determinants of bed net programme cost effectiveness and parameter values for usage rate, delivery
and retreatment cost from the literature. One-way sensitivity analysis was conducted to explicitly compare the
differential effect of changing parameters such as price, lifespan, usage and replenishment need.
Results: If conventional and long-lasting bed nets have the same physical lifespan (3 years), LLINs are more cost
effective unless they are priced at more than USD 1.5 above the price of conventional nets. Because a longer
lifespan brings delivery cost savings, each one year increase in lifespan can be accompanied by a USD 1 or more
increase in price without the cheaper net (of the same type) becoming more cost effective. Distributing
replenishment nets each year in addition to the replacement of all nets every 3-4 years increases the number of
under-5 deaths averted by 5-14% at a cost of USD 17-25 per additional person protected per annum or USD 1080-
1610 per additional under-5 death averted.
Conclusions: Our results support the World Health Organization recommendation to distribute only LLINs, while
giving guidance on the price thresholds above which this recommendation will no longer hold. Programme
planners should be willing to pay a premium for nets which have a longer physical lifespan, and if planners are
willing to pay USD 1600 per under-5 death averted, investing in replenishment is cost effective.
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Background
Distributing insecticide-treated bed nets (ITNs) has
become an integral component of national anti-malaria
programmes e.g. [1]. Within those programs, the World
Health Organization (WHO) [2] now recommends full
coverage of long lasting insecticide-treated nets (LLINs),
which means that each household should own one LLIN
for every two people living there [3]. LLINs were devel-
oped in the 1990s and first approved by the WHO Pes-
ticides Evaluation Scheme (WHOPES) in 2003. With the
entry of new manufacturers in recent years, LLINs have
become cheaper and more readily available. An LLIN
now costs around USD 4.5 [4-6] and provides effective
insecticide protection for at least 3 yearsa. By compari-
son, a conventional net costs considerably less and must
be retreated after 2-3 washes, or about every 6-12
months.
Few economic evaluations of LLIN distribution have
been published. Mueller et al. [7] found that distributing
LLINs within a measles vaccination campaign in Togo
compared favourably against other public sector ITN
programmes. Kolaczinski et al. [4] studied variation in
usage and delivery cost in Uganda. Yukich et al. [1]
used data from Togo and four conventional ITN pro-
grammes and concluded that in 3 of 5 cases, 5-year
LLINs were cost effective compared to conventional
ITNs and to 3-year LLINs. Other LLIN programmes
have been evaluated for programme effect only [8-12]
with the most common measures of effect being house-
hold bed net ownership and usage among children
under 5.
According to the WHO’s World Malaria Report 2010,
254 million ITNs, most of them LLINs, were distributed
in sub-Saharan Africa between 2008 and the first three
quarters of 2010, with a further 25 million ITNs sched-
uled for delivery by the end of 2010 [13]. Countries
which have launched large-scale LLIN distributions
include Togo, Madagascar, Zambia, Uganda, Nigeria,
Sierra Leone, Kenya, Niger, Rwanda, Tanzania, Ethiopia,
the Democratic Republic of Congo, and the state of
Orissa in India. However, other malaria programme
managers may be put off by the higher price of LLINs
and may be uncertain about their cost effectiveness rela-
tive to conventional ITNs.
Given the paucity of prospective data and the need for
an economic evaluation of LLINs that may be valid in
multiple settings, we constructed a simple model of the
cost effectiveness of LLINs. Our results suggest that
programme planners should be willing to pay a pre-
mium for LLINs over conventional nets, especially when
LLINs have a longer lifespan, and even when most con-
ventional nets are regularly retreated and retreatment
kits are inexpensive. More generally, we show how LLIN
programme cost effectiveness varies with bed net price,
lifespan, usage and loss rates. We also estimate that in
addition to the replacement of all nets every 3-4 years,
distributing a smaller number of replenishment nets
each year is incrementally cost effective if planners are
willing to pay USD 1600 per under-5 death averted. Our
model is intended to represent the costs of a large-scale
national programme over a relatively long time horizon
(10 years).
Methods
Literature review
Pubmed, JSTOR and Web of Science were searched
using the key words “malaria nets”, “malaria cost and
benefit analysis”, and “malaria nets cost effectiveness
analysis"; and “malaria nets” in combination with “inter-
vention”, “cost analysis”, “cost-benefit analysis”, “cost
effectiveness analysis”, “cost of illness”, “cost savings”,
“distribution cost”, “economic evaluation”, “household
costs” and “primary prevention”. References of all identi-
fied articles were then hand-searched to identify addi-
tional articles. The main literature search was conducted
between May and July 2010 and was restricted to peer-
reviewed articles published in 1990 or later. Where the
peer-reviewed article referred to a non-peer reviewed
article for more detailed results, we also consulted the
latter if necessary e.g. [1,14]. No language limiters were
used in the search, however articles in a foreign lan-
guage were not read except for any English-language
abstracts.
Model specification
Determinants of the cost effectiveness of bed net distri-
bution were identified from the literature review
described above as: price and lifespan of nets; procure-
ment and delivery costs; insecticide retreatment costs
(conventional ITNs only); replenishment need and costs;
effectiveness of nets; coverage and usage rates. We
derived parameter values for bed net effectiveness, cov-
erage and usage rates, delivery cost, and retreatment
need and cost from the literature review. A base case
was constructed whereby a large-scale programme
achieves high coverage and usage throughout the popu-
lation by distributing either LLINs or conventional nets
through existing health services, and retreating a large
proportion of conventional nets regularly at low cost.
This base case model served as a comparator against
which the effect of alternative parameter values and
assumptions was explicitly explored. In particular, the
effect of replenishment was explored through three
alternative scenarios. The values used in the base case
model, one-way sensitivity analyses and replenishment
scenarios are summarised in Table 1.
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Programme effect
To enable comparison of programme effect in a number
of settings, the main effect measure in our model is the
number of people protected. “People protected” refers to
the number of people who, on an average night, sleep
under an ITN. The strength, and weakness, of this mea-
sure is that it does not distinguish between users (adult
or child) nor does it require information of the local
transmission rate.
Our model assumes that the bed net programme tar-
gets a population of 4 million people of whom 20% are
aged under 5. Given this arbitrary population, we have
calculated programme effect using assumptions about
programme coverage, bed net usage and protective
effect that are based on studies of previous ITN pro-
grammes and current data on coverage and usage rates.
The base case parameter values are summarised in
Table 1. The calculation of programme effect (number
of people protected and under-5 deaths averted) is
detailed at the end of this section.
The RBM Partnership and the UN Secretary-General
called for universal coverage of malaria prevention and
treatment by the end of 2010. This would mean one
LLIN for every two people (coverage) and at least 80%
of people at risk from malaria using LLINs (usage) [3].
The RBM website provides an updated Progress Report,
which at the time of writing suggested that 25 countries
had reached 80% usage in their target populations [15].
WHO [13] estimates that 42% of African households
owned at least one ITN and usage among under-5 s was
35% in 2010. Certainly the most recent Malaria Indica-
tor Surveys (MIS) [16] indicate that coverage and usage
have increased considerably from levels reported in
Demographic and Health Surveys (DHS) [17] conducted
only few years earlier. However, the three MIS reports
from 2010 available at the time of writing (Kenya,
Malawi and Zambia) suggested the targets were still
some way away: on average, 58% of rural households
owned an ITN, and 49% of under-5 s and 45% of preg-
nant women slept under an ITN.
Our base case assumes that a usage rate of 50% in the
general population is achieved by distributing one net
for every four people. We assume that 20% of the popu-
lation are aged under 5, which gives a coverage of 0.8
under-5 s per net. This is comparable to 0.9 reported by
Mulligan et al. [18] and 1.0 assumed by Yukich et al.
[1]. Small-scale campaigns typically achieve higher levels
of coverage than 4 people per net (e.g. 1.3-2.4 people
per net in [4,19,20].
Our base case values of 4 people per net and 50%
usage are lower than the RBM universal coverage target
levels yet not dissimilar to levels suggested by those who
argue that relatively high coverage of the whole popula-
tion is the most effective way to protect vulnerable
groups because of community effects [21-23]. Commu-
nity effects exist if bed nets benefit non-users through a
reduction in the local parasite prevalence [24-29]. This
requires relatively high coverage and usage rates; e.g.
35-65% usage [23] or that over 50% of households own
enough ITNs to cover all household members levels, see
also [28,29].
Our assumption of 70% usage rate among under-5 s is
also below the RBM goal but optimistic given actual
usage rates measured after bed net distributions. Rates
above 60% are rarely reported (e.g. 52% [8], 36-81% [10],
56% [11]) although [30-32] report usage rates above
Table 1 Base case and sensitivity analysis values and sources
Variable Base case Sensitivity analysis Sources
Protective effectiveness of
ITNs
5.5 all-cause deaths are prevented per 1000
under-5 s protected every year
-
(estimate only relevant if usage is high)
[35]
Coverage: number of nets
relative to population size
1 million nets distributed to 4 million people,
20% aged under 5
- -
Usage rate in first year after bed
net distribution
50% overall
70% under-5 s
30% overall and 50% under-5 s;
30% both overall and under-5 s
See Methods -
Programme effect
ITN purchase price USD 4 USD 3 - USD 7 (LLINs)
USD 1 - USD 5 (conventional nets)
[4]
Bed net lifespan 3 years 3 - 5 years (LLINs) 1-4 years (conventional
nets)
[41,43]
Delivery cost and method USD 1.4 per net
Large-scale free integrated distribution
USD 3.86 per net
Subsidised sales and social marketing
See Table 2
Insecticide retreatment
(conventional nets only)
75% of nets are treated annually for USD 0.64
per net
50% treated annually or 75% treated
biannually for USD 1.28 per net
See Table 3
Replenishment need No replenishment need Increasing/constant/decreasing proportion
of nets is lost each year.
See Methods
-Replenishment
Replenishment net delivery
cost
- USD 1.4 or USD 3.86 per net See Table 2
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75%. There is some evidence to suggest that usage falls
over time [33] however this body of evidence is small;
therefore we assume that the proportion of nets used is
constant. In sensitivity analysis, we examine 30% overall
usage and 50% and 30% under-5 usage.
In the base case model in which there is no replenish-
ment need, LLIN programme effect is constant and cal-
culated as
PPLLIN = POP ∗ USE ∗ 10 (1)
PPLLIN = number of people protected using LLINs
over 10 years
POP = population
USE = average usage rate (%)
Conventional ITN programme effectb over the 10-year
period is calculated as:
PPITN = [R ∗NETS + RETREAT] ∗ POP ∗USE/NETS (2)
PPITN = number of people protected using conven-
tional ITNs over 10 years
R = number of ITN distribution rounds in the 10-year
period
NETS = number of nets in each round
RETREAT = number of retreatments delivered
between rounds
The first half in square brackets represents “treated
net-years” and the second half can be interpreted as the
number of people protected per net distributed.
When LLINs are lost over time and not replenished,
programme effect is the average number of people pro-
tected over a 10-year period. For each year t,
PP(t) = LOSS(t) ∗ POP ∗USE (3)
LOSS(t) is the loss rate, see section Methods - Replen-
ishment. When lost LLINs are annually replenished, we
assume that programme effect is the same as if there
was no replenishment need (1).
There is general consensus in the literature that ITNs
reduce malaria morbidity and mortality. Most evidence
concerns all-cause mortality, particularly among children
under 5 years old, although estimates of mortality and
morbidity directly attributable to malaria are also avail-
able [10,34]. The Cochrane review by Lengeler [35] esti-
mates that 5.5 all-cause deaths are prevented each year
for every 1000 under-5 children protected. This estimate
is based on small-scale studies in malaria-endemic areas
with high bed net coverage, and therefore serves as an
upper bound with a need for sensitivity analysis on this
value. Studies published after the Cochrane review are
not directly comparable, e.g. [36] only report malaria
cases averted and [37] focus on long-term effects when
ITN use was relatively low.
In the base case with high usage among children, we
multiply the number of under-5 s protected each year
by 5.5 per 1000 [35] to obtain the number of under-5
deaths averted, DA(t):
DA(t) = 5.5 ∗UP(t)/1000 (4)
UP(t) = no. under-5 s protected; calculated as (1) but
for the under-5 population using the under-5 usage rate.
We then assign 33 DALYs to each death of a child
under-5, giving the number of DALYs averted each year
(DALY(t)) as
DALY(t) = 33 ∗DA(t) (5)
This is equivalent to treating all child deaths as infant
deaths and discounting at 3% per annum [1,38]. Thereby
we follow the common approach in the bed net litera-
ture that DALYs averted are calculated from deaths only
e.g. [1,39].
Programme cost
Following the literature review, we decided upon a pre-
vention-only model and a modified provider perspective
such that the costs of treating malaria were excluded.
We assume that each bed net is characterised by its pur-
chase price, physical lifespan and the duration of insecti-
cide protection.
Sensitivity analyses tend to find that bed net price and
lifespan have a significant impact on programme cost
effectiveness e.g. [4,40]. However, the definition of life-
span is not universally agreed. In particular, should the
average lifespan in the field reflect the proportion of
nets lost to accidents or used for other purposes? We
follow WHO [13] and define LLIN lifespan simply as
the period during which LLINs retain full efficacy. The
lifespan of a conventional ITN is the period for which, if
regularly retreated, the net provides effective protection
against malaria. In our model, lifespan determines the
frequency of bed net distributions and the period over
which bed net costs are annualised.
In the base case model, we assume each bed net -
whether conventional or long-lasting - has a 3-year
lifespan and costs USD 4. For an LLIN to be approved
by the WHO Pesticides Evaluation Scheme
(WHOPES), at least 80% of the nets must pass tests
for effectiveness after being used by households in ran-
domised field trials lasting at least 3 years [41]. If a
manufacturer proposes say a 5-year lifespan, 80% of
nets must pass the tests after 5 years [42]. WHO [13]
also assumes an average ITN lifespan of 3 years, and a
maximum of 5 years. Evidence on physical lifespan
other than from WHOPES reports comes mainly from
small-scale research trials; e.g. Erlanger et al. [43]
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found that conventional ITNs subject to daily wear and
tear lasted two to three years.
WHO’s Global Price Reporting Mechanism [6] pro-
vides recent LLIN transaction price datac. For the 173
orders placed in 2010, the average unit price was USD
4.75 (range USD 3.3 to USD 7.9). There was no obvious
relationship between unit price and order size (average
USD 4.72 for orders of more than 100,000 LLINs). In
sensitivity analysis, we vary LLIN lifespan between 3 and
5 years and unit price between USD 3 and USD 7. The
choice of base case price is further supported by UNI-
CEF [5] who report a weighted average price of about
USD 4.5 for the first three quarters of 2010 and Kolac-
zinski et al. [4] who report recent quotes of USD 3.90
and USD 4.50 obtained by the Malaria Consortium
(USD 5.50 for small volume procurement). In sensitivity
analysis, we allow conventional nets to have a lower
purchase price (USD 1 - USD 5) and/or shorter lifespan
(1 - 4 years) than LLINs. The WHO database [6] pro-
vides only one record of an order for conventional nets
("non-treated bednet”) in 2010 for which the unit price
was USD 2.2.
We assume that new nets (of the same type) are dis-
tributed when nets reach the end of their lifespan. The
same number of nets is distributed in each of these
“main” rounds, and the cost of each round is given by
NETS * (bed net purchase price + domestic delivery
cost per net). In addition, lost nets may be replenished
through small annual distributions between main
rounds. Conventional ITN programmes also incur the
cost of retreating nets. See separate sections on Deliv-
ery cost, Replenishment, and Insecticide retreatment.
Total programme cost is the sum of main round,
replenishment and retreatment costs over 10 years less
the value of bed nets with lifespan remaining. Value
remaining is a share of the (discounted) last main
round cost, with the share equal to the proportion of
lifespan remaining, e.g. two-thirds for 3-year nets dis-
tributed in year 9.
Bed net price and delivery cost were annualised over
bed net lifespan using a discount rate of 3%. All costs
were discounted to year zero using a discount rate of
3%. Exchange rates presented in the original sources
and the US consumer price index were used to convert
all costs extracted from the literature to 2009 US
dollars.
Replenishment
The loss of nets over time reduces programme effect
and raises the potential need to distribute replenishment
nets. Nets may be lost because they i) are severely
damaged through wear and tear, fire or other accident;
ii) are used for other purposes; or iii) are sold or given
away to relatives. However, we found no published
evidence on the cost of replenishment, and very little on
replenishment need after the first year of use. Hassan et
al. [44] found that 131/142 (93%) of households who
had received LLINs still owned them 1.5 years later,
although some of these nets were totally damaged.
WHO [13] assumes that on average 4% of nets are dis-
carded each year.
We examine three different scenarios of the replenish-
ment need, which may or may not be met by distribut-
ing new nets. Scenario 1 is based on a model developed
by Albert Kiliand and assumes that the rate at which
nets are lost has an S-shape: it increases over time, until
50% of the originally distributed nets are remaining, and
subsequently slows down. We applied the model assum-
ing that 50% of nets have been lost when the nets come
to the end of their lifespan. The proportion of nets
remaining in preceding years is given by:
no. nets remaining (t)
no. nets distributed (t = 0)
= exp
(
k − k
1 − (t/L)2
)
(6)
where k is the bed net lifespan (in years) and t is the
number of years since the distribution. L is a parameter
that depends on lifespan. First we solve for L for values
of k between 2 and 5 using the assumption that when t
= k, 50% of nets are remaining. Given the value of L,
the proportion of nets remaining at any time t is then
easily computed. For example, for nets with a 3-year
lifespan, 93.8% are remaining in the second year after
the distribution, 76% in the third year, and 50% in the
fourth year.
In Scenario 2, the annual loss is a constant proportion
of the nets originally distributed i.e. each net has a con-
stant probability of being lost. We assume that the same
number of nets are lost each year, equal to 5% or 10%
of the nets originally distributed. Scenario 3 is similar to
the one assumed in WHO [13]: a constant proportion -
we assume 5% or 10% - of nets currently owned is lost
each year and thus the probability of being lost
decreases over time.
We make several simplifying assumptions regarding
the structure of a replenishment programme. First, the
replenishment need is met through annual replenish-
ment distributions. Second, replenishment nets are
bought at the same time as nets used in the main distri-
bution round, and are stored at negligible cost until dis-
tributed. Third, the replenishment delivery cost per net
is the same as in the main round (Table 2), although
distribution method may differ. Finally, all nets includ-
ing replenishment nets are replaced at each main distri-
bution round. We consider the simplicity of these
assumptions justified as a first attempt to include a
replenishment programme into a model of ITN cost
effectiveness.
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Delivery cost
The evidence on distribution cost is relatively scarce,
although recent evidence has emerged suggesting it var-
ies with the method of distribution. Kolaczinski et al. [4]
found that the antenatal care channel (USD 4.5 per net
delivered) was more expensive than two targeted distri-
bution campaigns (USD 3.7 and USD 3.0 respectively,
2009 USD). De Allegri et al. [40] estimated that distribu-
tion cost in Burkina Faso was USD 4.8 per net (2006
USD) for both the antenatal care channel and subsidised
sales.
We identified 17 studies that specified the distribution
method and reported economic cost data in sufficient
detail for us to calculate “delivery cost” per net, defined
in [1,4,14] as: Delivery cost per net = (Programme eco-
nomic cost - Price of nets - Price of insecticide)/Number
of nets delivered.e We divided our delivery cost estimates
into three groups depending on the distribution method
used in the original study, and calculated the average
cost of each method. The three different methods repre-
sented in the 17 studies are broadly described as: free
campaign distribution (nets are supplied at village col-
lection points or delivered directly to the doorstep), free
distribution integrated into routine services (typically
antenatal care), and subsidised sales supported by social
marketing. The average costs and sources are reported
in Table 2.
Our data suggests scale effects: the seven larger pro-
grammes (750,000 nets or more) cost on average USD
2.2 per net and at most USD 4.7 [18], while the maxi-
mum for smaller programmes (at most 65,000 nets) was
USD 9.0 [19] and the average USD 3.3.
Our base case delivery cost is USD 1.4 per net, the
average for large-scale integrated distribution. Although
small compared to De Allegri et al. [40] and Kolaczinski
et al. [4], our figure is in fact likely to be an overesti-
mate because only the cost of insecticide, not the full
cost of delivering retreatments, is subtracted. Two
small-scale studies [19,45] separately reported insecticide
and total retreatment costs. The proportion of insecti-
cide commodity cost in total retreatment cost was 27%
and 79% respectively (Table 3), which gives little indica-
tion as to the likely size of the bias. Overestimation of
delivery cost means that nets which are more frequently
distributed (i.e. have a shorter lifespan) will appear
somewhat more expensive. However, the size of this
bias is likely to be small given that the proportion of
delivery cost in total cost is small. The sensitivity of our
results to delivery cost is examined in sensitivity
analysis.
Table 2 suggests that subsidised sales (with social
marketing) and campaign delivery are more expensive
on average than routine service delivery. We use USD
3.86 (subsidised sales) in the sensitivity analysis, because
all the five examples of free campaign delivery are
small-scale campaigns.
Insecticide retreatment costs and frequency
In order not to bias our findings against conventional
ITNs, the base case in our model represents a “best case
scenario” with respect to the retreatment of conven-
tional ITNs. We assume that 75% of conventional nets
are successfully retreated annually at a cost of USD 0.64
per net treated.
Our literature search revealed two small-scale studies
which report a cost of USD 0.8 - 0.9 per retreatment
[19,45]. Five other studies report the commodity cost of
insecticide [14,36,39,46,47]. The difficulties in separating
out the full costs of retreating conventional ITNs from
other programme costs are discussed in Yukich et al.
[1,14]. To make use of the available data, we estimated
retreatment cost from the seven studies by dividing
insecticide cost by the number of retreatments and
initial impregnations. The median cost is our base case
Table 2 Delivery cost estimates
Delivery method Delivery cost per net (average and
range; USD 2009)
Country and source
Free campaign distribution (collection
points or door-to-door)
2.73 (0.7, 9.0) Uganda* (separate data for two districts) [4], Kenya [19],
Ghana [45], India [36]
Free distribution integrated to routine
services (small scale)
2.65 (1.66, 3.95) Burkina Faso [40], Uganda* [4], Dem. Rep. Congo [51]
Free distribution integrated to routine
services (large scale)
1.40 (0.78, 1.81) Malawi† and Togo [14]; Eritrea [46]
Subsidised Sales and Social Marketing 3.86 (1.34, 7.87) Tanzania†† [14,39,47], Malawi† [50], Burkina Faso [40],
Senegal [14]
Notes to Table 2. Studies that reported financial costs only e.g. [22,62] were excluded.
* For Uganda, [4] report costs for two delivery channels in two districts: campaign delivery in both districts, and delivery through antenatal care in one district.
† The Malawi programme relied more heavily on sales in the early years and routine service delivery later on. We classify Stevens et al. [50] as sales but Yukich et
al. [14] as integrated delivery because the latter include two additional years of data.
†† For Tanzania we use different sources for different programmes: Yukich et al. [14] for SMARTNET, Mulligan et al. [47] for TNVS, and Hanson et al. [39] for
KINET.
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estimate. The sources and estimates are reported in
Table 3.
Only considering the commodity cost of insecticide
means that we underestimate the true cost of conven-
tional ITNs. In the sensitivity analysis, we therefore dou-
ble the cost to USD 1.28, which reflects the Yukich et al.
[14] estimate that the share of insecticide in total
retreatment cost is 50%; Wiseman [19] and Binka [45]
report 27% and 79% respectively.
The paucity of evidence on retreatment cost may
partly be explained by low retreatment rates. Mulligan
et al. [18] found that 69% of mothers given a retreat-
ment kit used it to retreat their nets. Marchant et al.
[48] found that low retreatment was the main reason for
low ITN coverage. Armstrong Schellenberg et al. [49]
conclude that most of those households who had tried
retreatment did not make a regular habit of it. Indeed,
the WHO (2008) cited difficulties in effectively deliver-
ing retreatment as a reason for recommending the move
conventional nets to LLINs. In sensitivity analysis, we
reduce the retreatment rate from 75% to 50%.
Typically the initial impregnation and subsequent
retreatments are assumed to provide either 6 months or
1 year of protection e.g. [1,47,50] and the other value is
assumed in sensitivity analysis. This assumption can
have a significant effect on programme cost effective-
ness. For example, Yukich et al. [1,14] conclude that if
insecticide lasts for one year, conventional nets are as
cost effective as LLINs in two out of five large-scale pro-
grammes, but if retreatment is required every six
months, LLINs are more cost effective in all five cases.
Reducing the duration of insecticide protection from 1
year to 6 months has approximately the same effect as
doubling the cost of retreatment, which is why we do
not separately report on sensitivity analysis for the dura-
tion of insecticide protection.
Results and discussion
Long-lasting versus conventional ITNs in the base case
LLINs are more cost effective than conventional ITNs in
the base case in which there is no difference in purchase
price or lifespan. Each delivered LLIN costs USD 5.14
on average over the 10-year period. A conventional net
that is regularly retreated with insecticide costs USD
6.94 on average. The difference of USD 1.80 per net is
explained by a higher total cost (due to the additional
cost of retreatment) and a smaller programme effect
(fewer treated net-years due to a 75% retreatment rate)
in the conventional net programme. The annual cost is
USD 1.71 per LLIN and USD 2.31 per treated conven-
tional net.
The base case represents a highly effective pro-
gramme. On average over 10 years, 850,000 of the 1
million conventional nets distributed provide effective
protection for 1.70 million people including 476,000
children under 5 each year. The annual cost is USD
1.16 per person or USD 4.13 per child. An estimated
26,180 deaths, equivalent to about 864,000 DALYs, are
averted over 10 years.
Using LLINs improves cost effectiveness by 26%. The
number of people protected is 2 million each year,
including 560,000 children under 5, at an annual cost of
USD 0.86 per person or USD 3.06 per child. An esti-
mated 30,800 child deaths, equivalent to some 1.02 mil-
lion DALYs, are averted over 10 years, at a cost of USD
556 per death or USD 16.8 per DALY averted. The cost
saving compared to conventional ITNs is equal to USD
1.07 per under-5 (USD 0.30 per person) protected per
Table 3 Insecticide retreatment cost estimates
Scale Retreatment
frequency
Cost of insecticide per retreatment kit
(USD 2009)
Total cost per retreatment
(USD 2009)
Country and
source
Small scale (≤ 65,000
nets)
Biannual 0.21 0.78 Kenya [19]
Biannual 0.69 0.87 Ghana [45]
Continuous sales 1.67 - Tanzania† [39]
Initial impregnation
only
0.32 - India [36]
Large scale (≥ 0.75 m
nets)
Annual 0.67 - Malawi†† [14]
Annual 0.23 - Eritrea [46]
Continuous sales 2.05 - Senegal [14]
Continuous sales 0.61 - Tanzania† [14]
Biannual 0.80 (1.16 for kits actually used) - Tanzania† [47]
Notes to Table 3. † For Tanzania we use different sources for different programmes: Yukich et al. [14] for SMARTNET, Mulligan et al. [47] for TNVS, and Hanson et
al. [39] for KINET.
†† We use Yukich et al. [14] rather than Stevens et al. [50] because the former include two additional years of data.
Pulkki-Brännström et al. Cost Effectiveness and Resource Allocation 2012, 10:5
http://www.resource-allocation.com/content/10/1/5
Page 7 of 13
year, equivalent to USD 195 per death averted or USD
5.90 per DALY averted. How changes to the parameters
of the base case change the above results is discussed in
the following sections.
Bed net price and lifespan
The LLIN is the more cost effective option if LLINs and
conventional nets have the same lifespan, unless the
LLIN price is above a certain threshold. In the base
case, the price differential must be greater than USD
1.5. For example, if the 3-year conventional ITN is
priced at USD 2.4 and the 3-year LLIN at USD 4, or the
conventional net is USD 4 and the LLIN USD 5.9, then
the two nets are equally cost effective. The price differ-
ential necessary to change cost effectiveness in favour of
conventional nets is larger if the retreatment rate is less
than 75%, the retreatment need more frequent, or the
retreatment cost larger. For example, if the retreatment
rate is 50% (or either retreatment is biannual or the cost
per retreatment is USD 1.28), the conventional net must
be priced at USD 1.9 (1.6) to be cost effective against
the LLIN which costs USD 4.
A longer lifespan also brings delivery cost savings. For
example, using 5-year LLINs instead of 3-year LLINs
reduces the cost per under-5 death averted by USD 204
in the base case if there is no difference in price. Gener-
ally, we find that price can increase by USD 1 or more
for each one-year increase in lifespan, if nets are of the
same type.
Figure 1 illustrates bed nets of different price, lifespan
and type which are equally cost effective as the 3-year
LLIN at USD 4. In this case, a 4-year LLIN at more
than double the price of a 3-year conventional net (USD
5.6 vs. USD 2.4) is equally cost effective, and a 2-year
advantage in lifespan can be accompanied by nearly a
tripling of the price (USD 7.0). Thus if LLINs can offer
a longer lifespan, programme planners should be willing
to pay a considerably higher price for LLINs than for
conventional nets. As we have demonstrated, this is the
case even in programmes which inexpensively retreat a
large proportion of conventional nets. The advantage
that LLINs have over conventional nets - that they do
not have to be retreated - is magnified for each addi-
tional year of useful life.
Importance of usage rate for programme effect
Programme effect falls proportionally with reductions in
the usage rate. Given the same number of nets as in the
base case, a 40% reduction in the usage rate from 50%
to 30% means 0.8 million (40%) fewer people are pro-
tected each year compared to the base case. Conse-
quently, cost per person protected rises to USD 1.43 per
year from USD 0.86 in the base case (63% increase).
This relationship between the usage rate and pro-
gramme cost effectiveness is illustrated in Figure 2. If
the programme uses conventional nets, the same reduc-
tion in usage means that cost per person increases from
USD 1.16 to USD 1.93 per year (66% increase) as
680,000 fewer people on average are protected each
year.
Our base case with 1 net per 4 people and 50% usage
represents a more cost effective programme than one
that reaches GMAP and RBM’s target coverage and
usage values of 1 net per 2 people and 80% usage. This
is because with 1 net per 4 people, 40% usage would be
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Figure 1 Equally cost effective bed nets of different price,
lifespan and type. Each bed net choice is as cost effective as the
base case, the 3-year LLIN priced at USD 4. Programme cost is USD
1.71 per net delivered (and retreated) per annum, USD 0.85-0.86 per
person (USD 3.05-3.06 per under-5) protected per annum, USD 554-
556 per under-5 death averted and USD 16.8-16.9 per DALY averted.
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Figure 2 Relationship between usage rate and programme
cost effectiveness when programme cost is constant. The figure
illustrates how cost effectiveness changes depending on how
frequently nets are used. The base case is 50% usage among the
general population and 70% among under 5s, which gives LLIN
cost effectiveness as USD 0.86 per person protected and USD 3.06
per under-5 protected. If conventional nets are used instead (with
the same physical lifespan and purchase price and base case
assumptions about retreatment), cost effectiveness is USD 1.16 per
person protected. A higher usage rate implies a lower cost per
person protected.
Pulkki-Brännström et al. Cost Effectiveness and Resource Allocation 2012, 10:5
http://www.resource-allocation.com/content/10/1/5
Page 8 of 13
sufficient for a programme to be equally cost effective as
one with 80% usage and 1 net per 2 people. The com-
parison is somewhat theoretical however, as in practice
distributing a given number of nets to twice the popula-
tion would be expected to affect programme cost.
Returning to LLINs, if the under-5 usage rate is 50%
(30%), 160,000 (320,000) fewer children are protected
each year than in the base case (70% usage) and cost
per under-5 increases from USD 3.1 to USD 4.3 (7.1)
per year. We do not report cost per death averted here
because the Lengeler [35] estimate of protective efficacy
applies only in high usage settings (see Methods - Pro-
gramme effect).
Replenishment
The cost of replenishment depends on the loss rate, the
type of nets distributed, and delivery cost. In the follow-
ing discussion we only consider LLINs in order to
abstract from the cost of retreating conventional nets in
combination with replenishing lost nets. In Scenario 1,
where the number of nets lost increases over time, some
62,000 nets must be distributed in the beginning of the
second and 177,000 nets in the third year after each
main distribution round in order to keep the number of
people protected constant until the next main distribu-
tion round in year 4. Assuming nets are priced at USD
4 and the delivery method is the same as in the main
rounds (delivery cost of USD 1.4 per net), the six
replenishment rounds over 10 years increase overall
programme cost by 26%. In Scenarios 2 and 3 a con-
stant proportion of nets distributed/remaining is replen-
ished annually. If this is 10%, replenishment increases
programme cost by 22%. Halving the annual replenish-
ment need to 5% also halves the increase in cost to 11%.
Scenario 1 indicates a larger replenishment need than
Scenarios 2 and 3 if lifespan is less than 4 years. If life-
span increases, the three scenarios converge: fewer nets
are needed in Scenario 1 while more are needed in Sce-
narios 2 and 3. 4-year nets require seven replenishment
rounds, which implies one additional replenishment
round in Scenarios 2 and 3 but 72,000 fewer nets overall
in Scenario 1 (37,00 nets in year 2, 106,000 in year 3
and 162,000 in the year before the next main distribu-
tion). In this case, the S-shape assumption and a 10%
annual replenishment need both imply that replenish-
ment increases total cost by 33%.
In Table 4 we present the incremental cost effective-
ness of replenishment in three scenarios and for both 3-
and 4-year LLINs. Scenario 2 has the smallest annual
replenishment need: 5% of distributed nets. Replenish-
ment increases programme cost by 11-26% (17-33%) if
lifespan is 3 (4) years. Note that the cost of replenish-
ment in Scenario 2 is now exactly half of that in Sce-
nario 3. Replenishment increases the number of under-5
deaths averted by 5-10% (7-14%) if lifespan is 3 (4)
years. A programme without replenishment is somewhat
more cost effective; for example, USD 701 vs. USD 611
per death averted in Scenario 1. The cost of
Table 4 Impact of replenishment on LLIN programme cost and cost effectiveness
Result Lifespan Scenario 1: S-
shaped loss rate
Scenario 2: 5% of
distributed nets lost
p.a.
Scenario 3: 10% of
remaining nets lost p.
a.
Number of replenishment nets required 3 years 717,000 300,00 600,000
4 years 644,600 350,000 700,000
Total replenishment cost (delivery cost) 3 years USD 4.47 m (USD
906,000)
USD 1.87 m (USD
382,000)
USD 3.75 m (USD
767,000)
4 years USD 4.32 m (USD
816,000)
USD 2.17 m (USD
443,000)
USD 4.34 m (USD
886,000)
Impact of replenishment on programme cost 3 years +26% +11% +22%
4 years +33% +17% +33%
Impact of replenishment
on programme effect
(under-5 deaths averted)
3 years 2780 more
deaths averted
(+9.9%)
1386 more deaths
averted (+4.7%)
2680 more deaths
averted (+9.5%)
4 years 3087 more
deaths averted
(+11%)
2002 more deaths
averted (+7.0%)
3764 more deaths
averted (+14%)
Cost per under-5 death averted with (without) replenishment 3 years USD 701 (611) USD 617 (582) USD 678 (609)
4 years USD 567 (474) USD 497 (456) USD 568 (486)
Incremental cost effectiveness of replenishment: cost per
additional under-5 death averted (per person protected p.a)
3 years USD 1609 (25) USD 1353 (21) USD 1399 (22)
4 years USD 1400 (22) USD 1085 (17) USD 1154 (18)
Notes to Table 4: All nets are LLINs priced at USD 4 each. Other variables take values specified in the base case model (Table 1).
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replenishment is USD 17-25 per additional person pro-
tected per annum or USD 1080-1610 per additional
under-5 death averted.
The incremental cost effectiveness of replenishment is
not very sensitive to replenishment delivery cost because
this is a relatively small proportion of total replenish-
ment cost. For example, increasing delivery cost by
some 2.5 times to USD 3.86 per net (the average for
subsidised sales and social marketing, see Table 2)
increases the incremental cost of replenishing 3-year
LLINs by 34%. The total cost of replenishment increases
by 7.0%/3.3%/6.1% in Scenario 1/2/3, giving a cost of
USD 33/28/29 per additional person protected per
annum or USD 2151/1811/1873 per additional under-5
death averted.
Limitations
The generalisability of cost effectiveness results from
past to future programmes, or across programmes of
different scale, is hindered by the relative lack of evi-
dence on some key determinants of programme cost
and effect, as well as the complexity of the relationships
involved. Our literature review identified the following
elements of the full (provider) costs on which there is
little or no published evidence: international transport
costs and transaction costs relating to the bed net pro-
curement process. We suspect two reasons for why
these cost categories have not been discussed: i) the
short time scale of most evaluations, and ii) modified
provider perspective are the norm and as such, costs
incurred by the procuring body (e.g. donor) are not
included.
International transport costs do not affect the choice
of net as long as manufacturers are located in the same
region, however import taxes and tariffs will be relevant
for individual countries and for the comparison of pro-
gramme costs across countries. With the exception of
Becker-Dreps et al. [51] and Yukich et al. [1,46], interna-
tional shipping costs are not discussed in the bed net lit-
erature. Yukich et al. [46] use the commodity, insurance
and freight (CIF) price of bed nets, and Yukich et al. [1]
use either the CIF price or the full retail price plus sub-
sidies. WHO-CHOICE [52] (see also [53]) suggest esti-
mating international shipping costs by multiplying
commodity prices by a so-called CIF/FOB mark-up,
equal to 25% and 44% for the WHO regions South East
Asia D and Africa D respectively. Because the effect of
such a mark-up on our results is similar to changes in
bed net price, which we already discuss at length, we do
not report on the results here. We presume that the
lack of data is either because the cost is already included
in the price paid for nets or international transport cost
is incurred by donors of nets (e.g. Becker-Dreps et al.
[51] report that nets donated by the Global Fund were
valued at USD 8 including shipping and customs).
Procurement overheads, on which we could not find
any evidence, are nevertheless likely to be of increasing
relevance to programme planners and evaluations with
repeated bed net purchasing and distribution. We would
expect that the procurement of bed nets incurs over-
heads such as the costs of a tender process. We consid-
ered the effect of an arbitrary fixed cost of USD 200,000
for every main distribution round on the results in Fig-
ure 1 and found that the price of the 5-year LLINs
could increase to USD 7.2 but otherwise a cost of this
magnitude (3.7% of total programme cost over 10 years)
has little impact on the relative cost effectiveness of nets
with different lifespans (results not reported). The lack
of literature on overheads may be because these costs
are absorbed into overall programme cost e.g. [1,19] or
again because these costs are commonly incurred by
donors. In the long run however, such costs should not
be ignored, particularly if local ownership of pro-
grammes is being encouraged alongside the sustainabil-
ity of interventions and if the frequency of required bed
net distributions is high.
We treat the usage rate rather simplistically in our
model because evidence on its determinants and varia-
tion over time is relatively scattered. Consistent with the
findings of Yukich et al. [1] and Kolaczinski et al. [4],
we assume that the distribution channel does not lead
to significant differences in usage or retention. Specifi-
cally, paying for a net does not appear to be associated
with a greater likelihood of use [54,55].
A limitation of our model is that we do not address
issues of equity. Our sensitivity analysis is also limited
by the lack of evidence on the efficacy of nets when cov-
erage or usage is low. We have overcome the issue in
part by referring to the number of people protected.
Other issues around programme effect discussed in the
literature but excluded from our model because of the
relatively small evidence base are the protective efficacy
of untreated nets and nets used beyond their lifespan,
and the long-term effects of ITN use. There is some evi-
dence that unprotected nets i.e. conventional ITNs
which have not been treated with insecticide in the last
6-12 months, provide protection against malaria [56,57].
Long-term effects are a concern if, without repeated
exposure to malaria, malaria infections are simply post-
poned to later in childhood when the morbidity effects
may be even more serious [58,59]. Askjaer et al. [60]
find evidence of lower levels and less diversity of antibo-
dies, while others find no evidence of negative long-
term effects [26,61].
While our assumption that nets are discarded and
replaced at the end of their lifespan may underestimate
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true programme effect, long-term effects would imply
that our model overestimates effect. We thus implicitly
assume that the two effects cancel out. We also consider
our simplified approach to programme effect justified
because of its transparency. As a first step, we would
suggest extending our model so that protection offered
by replenishment nets is calculated from the date of
delivery rather than the date of procurement. However,
we expect that our current specification better mirrors
true programme cost because programme managers
may prefer to use a simple, transparent formula, as we
have done here.
Conclusions
This paper uses a modelling approach to integrate the
available evidence on the cost effectiveness of conven-
tional and long-lasting ITNs. Our discussion focuses
particularly on those factors which decision-makers
facing a choice of nets should consider. Our results sup-
port the WHO [2] recommendation to distribute only
LLINs, in particular if LLINs have a longer lifespan. Our
analysis also identifies the pricing thresholds above
which this recommendation will no longer hold.
In our base case, LLINs are 26% more cost effective
than conventional nets. The difference is large, consider-
ing that we have assumed a successful conventional ITN
programme in which a high proportion of nets are
retreated at a low cost. The cost saving offered by
LLINs is equal to USD 0.30 per person protected per
year, or USD 195 per under-5 death averted. If conven-
tional nets and LLINs have the same lifespan (3 years),
LLINs are more cost effective unless they are priced at
more than USD 1.5 above the price of conventional
nets. Because a longer lifespan brings delivery cost sav-
ings, each one year increase in lifespan can be accompa-
nied by a USD 1 or more increase in price without the
cheaper net (of the same type) becoming more cost
effective.
In line with previous studies, we find that cost effec-
tiveness is highly sensitive to the usage rate. If the
(LLIN) programme achieves a 50% (30%) under-5 usage
rate rather than the 70% assumed in the base case, the
cost per under-5 protected is USD 4.3 (7.1) rather than
USD 3.1 per year.
We estimate that if programme planners are willing
to pay USD 1600 per under-5 death averted, investing
in replenishment is cost effective. As LLINs become
increasingly common, we suspect that attention of pro-
gramme planners and academics alike will turn
increasingly to the issue of replenishment: what is the
replenishment need (or loss rate), how should replen-
ishment be carried out, if at all, and at what cost.
Thus more publicly available data on the replenish-
ment need and its determinants would be highly
valuable. One concern with the move to LLINs is
whether less frequent distribution and the cessation of
retreatment activities - as would be the case with
LLINs - would negatively affect usage rates. The evi-
dence is currently unable to predict whether this
would be the case.
Endnotes
aSee pages 10-11 for WHOPES approval conditions.
bThe formula assumes that insecticide protection lasts
for 1 year. If duration is 6 months, a multiplier of 0.5
should be used.
cWe thank a reviewer for suggesting this resource.
dOur operationalisation of Scenario 1 directly draws
on a formula developed by Nakul Chitnis of the Swiss
Tropical Institute. Albert Kilian of the Malaria Consor-
tium shared this formula with us through personal cor-
respondence. Kilian has synthesised the available (but as
yet unpublished) evidence on the loss of nets over time.
eFor studies that only reported annual economic cost,
we estimated delivery cost as: (Annual economic cost -
Price of nets - Price of insecticide) * Length of programme
(years)/Number of nets delivered.
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